

GATT Technologies, a Dutch provider of hemostatic solutions, has secured 10.5 million euros in Series B financing. NGI LLC led the round with participation from Johnson & Johnson Innovation – JJDC, Inc. and Oost NL.
Source: Press Release
GATT Technologies, a Dutch provider of hemostatic solutions, has secured 10.5 million euros in Series B financing.
GATT Technologies, a Dutch provider of hemostatic solutions, has secured 10.5 million euros in Series B financing. NGI LLC led the round with participation from Johnson & Johnson Innovation – JJDC, Inc. and Oost NL.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination